Press release
Myelofibrosis Therapeutics Pipeline Analysis Report - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments
Request to Get the Sample Report@ https://www.psmarketresearch.com/market-analysis/myelofibrosis-therapeutics-pipeline-analysis/report-sample
Various companies, educational institutes and medical organization are collaborating for the development of therapeutics for the treatment of myelofibrosis. For instance, Geron Corporation and Janssen Pharmaceuticals, Inc. entered into a collaboration agreement, in which Geron Corporation granted an exclusive worldwide right to Janssen, for the development and commercialization of imetelstat for all human therapeutic uses, including hematologic myeloid malignancies.
Explore Full Report Description At@https://www.psmarketresearch.com/market-analysis/myelofibrosis-therapeutics-pipeline-analysis
According to the research, there are several companies having drug candidates in their pipeline, using synthetic sources for the development of drugs for the treatment of myelofibrosis. Imetelstat is an oligonucleotide obtained from synthetic source that acts as telomerase inhibitor.
Some of the key players developing drugs for myelofibrosis include CTI BioPharma Corporation, Geron Corporation, Gilead Sciences, Inc. and others.
About P&S Market Research
P&S Market Research is a global market research and consulting company. We provide market research reports, industry reports, business intelligence and research-based consulting services across a range of industries.
With the help of our professional corporate relations with various companies, our market research offers the most accurate market forecasting. Our analysts and consultants interact with leading companies of the concerned domain to substantiate every single data presented in our publication. Our research assists our client in identifying new and different windows of opportunity and frame informed and customized strategies for expansion in different regions.
Contact:
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myelofibrosis Therapeutics Pipeline Analysis Report - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments here
News-ID: 1141568 • Views: …
More Releases from P&S Market Research - Life Sciences
Prostatitis Therapeutics Pipeline Analysis Report - Clinical Trials & Results, P …
The study analyzed that the prostatitis therapeutics pipeline comprises 11 drug candidates in different stages of development. Prostatitis is an infection or inflammation of the prostate gland that can lead to various syndromes with varying clinical features. The term prostatitis is defined as microscopic inflammation of the tissue of the prostate gland and it occurs due to a broad range of clinical conditions. The National Institutes of Health (NIH) has…
Biobanking Market by Product and Service, Sample Type, Application, Storage Type …
Biobanks are biological repository of human samples and related data which is utilized in biological research for investigating therapeutic approaches to ameliorate various diseases. Bio-specimens are characterized to determine the features of a continuous cell line, identification of contaminants and gaining profound knowledge of the raw materials utilized in the preparation of the bio-products. The process of collection of these specimens and extraction of useful information into a repository for…
More Releases for Myelofibrosis
Primary Myelofibrosis (PMF) Market Insights and Future Outlook
Introduction
Primary myelofibrosis (PMF) is a rare, chronic myeloproliferative neoplasm characterized by progressive bone marrow fibrosis, splenomegaly, anemia, and systemic symptoms such as fatigue, night sweats, and weight loss. Unlike secondary myelofibrosis, which arises from other blood cancers, PMF develops as a distinct disease entity, typically driven by mutations in JAK2, CALR, or MPL genes.
PMF has long been associated with poor prognosis and limited therapeutic options. Historically, treatment focused on symptom…
Myelofibrosis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Myelofibrosis Pipeline Insight 2024" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in Myelofibrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Myelofibrosis Research. Learn more about our innovative…
Secondary Myelofibrosis Therapeutics Market - Revolutionizing Treatment for Seco …
Newark, New Castle, USA: The "Secondary Myelofibrosis Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Secondary Myelofibrosis Therapeutics Market: https://www.growthplusreports.com/report/secondary-myelofibrosis-therapeutics-market/8885
This latest report researches the industry structure,…
Myelofibrosis Market - Transforming Challenges into Triumphs: Myelofibrosis Mark …
Newark, New Castle, USA: The "Myelofibrosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Myelofibrosis Market: https://www.growthplusreports.com/report/myelofibrosis-market/8802
This latest report researches the industry structure, sales, revenue, price and…
Secondary Myelofibrosis Therapeutics Market - Unleashing Resilience, Defying Mye …
Newark, New Castle, USA - new report, titled Secondary Myelofibrosis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Secondary Myelofibrosis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Secondary Myelofibrosis Therapeutics market. The report offers an overview of…
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,…
